Table 1.
Sociodemographic features and visit type use for patients during pre‐COVID‐19 (March 2019‐Feburary 2020) and COVID‐19 (April 2020‐March 2021) periods
| Patients, pre‐COVID‐19 period (n = 1503) | Patients, COVID‐19 period (n = 1442) | |
|---|---|---|
| n (%) | n (%) | |
| Age, years | ||
| <55 | 843 (56.1) | 850 (58.9) |
| 55‐64 | 363 (24.2) | 310 (21.5) |
| 65‐74 | 216 (14.4) | 193 (13.4) |
| ≥75 | 81 (5.4) | 89 (6.2) |
| Sex | ||
| Female | 1011 (67.3) | 968 (67.1) |
| Male | 491 (32.7) | 473 (32.8) |
| Distance from hospital, miles | ||
| <10 | 596 (39.7) | 606 (42.0) |
| 10‐24 | 498 (33.1) | 485 (33.6) |
| 25‐49 | 200 (13.3) | 172 (11.9) |
| 50‐99 | 98 (6.5) | 86 (6.0) |
| ≥100 | 111 (7.4) | 92 (6.4) |
| Race/ethnicity | ||
| White | 692 (46.0) | 635 (44.0) |
| American Indian or Alaska Native | 27 (1.8) | 28 (1.9) |
| Asian | 182 (12.1) | 164 (11.4) |
| Black or African American | 234 (15.6) | 215 (14.9) |
| Native Hawaiian or other Pacific Islander | 21 (1.4) | 26 (1.8) |
| Latinx | 232 (15.4) | 242 (16.8) |
| Missing | 115 (7.7) | 132 (9.2) |
| Language | ||
| English | 1187 (79.0) | 1121 (77.7) |
| Spanish | 160 (10.6) | 174 (12.1) |
| Non‐English/non‐Spanish a | 156 (10.4) | 147 (10.2) |
| Payer | ||
| Commercial | 439 (29.2) | 423 (29.3) |
| Self‐pay | 59 (3.9) | 77 (5.3) |
| Medicaid | 354 (23.6) | 340 (23.6) |
| Medicare | 336 (22.4) | 285 (19.8) |
| Other | 315 (21.0) | 314 (22.0) |
| Patient portal login | ||
| No | 533 (35.5) | 455 (31.6) |
| Yes | 970 (64.5) | 987 (68.4) |
| Established patient b | ||
| No | 922 (61.3) | 956 (66.3) |
| Yes | 581 (38.7) | 486 (33.7) |
| Visits | ||
| In person | 3836 (100) | 1382 (40.6) |
| Telemedicine | 0 (0) | 1036 (30.4) |
| Phone | 1 (0) | 988 (29.0) |
Abbreviation: COVID‐19, coronavirus disease 2019.
a
Most frequent non‐English/non‐Spanish languages, in descending order: Vietnamese, Amharic, Cambodian, Cantonese, Somali, Panjabi (Punjabi), Arabic, Tagalog, Farsi (Persian), Russian, and Tigrinya.
b
Established patient: any patient completing three or more visits during the pre‐COVID‐19 period.